Hunt BioVentures Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Investments
-
17
- Portfolio
-
1
- Exits
-
14

Hunt BioVentures General Information
Description
Hunt BioVentures was a venture capital firm that used to makes investments in young private and public firms with a focus on pharmaceuticals, medical devices and agricultural biotech opportunities. It was founded in 2001 and was based in Dallas, Texas.
Contact Information
Website
www.huntbioventures.com
Year Founded
2001
Investor Status
Out of Business
Primary Investor Type
Venture Capital
Primary Office
- 1900 North Akard Street
- Dallas, TX 75201
- United States
Hunt BioVentures Investments (17)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Raven | 02-May-2018 | Later Stage VC | 00.00 | Media and Information Services (B2B) | Generating Revenue | |
Revance Therapeutics | 16-Jan-2014 | 00000 00000 | 000.00 | Drug Delivery | Generating Revenue/Not Profitable | |
OvaScience | 04-Apr-2012 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | |
Synageva BioPharma | 22-Oct-2009 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | |
Cempra Pharmaceuticals | 14-May-2009 | 00000 00000 | 0000 | Pharmaceuticals | Profitable | |
InteKrin | 19-Mar-2008 | 00000 00000 | 000.00 | Pharmaceuticals | Clinical Trials - General | |
IntelliDx | 19-Mar-2008 | 00000 00000 | 000.00 | Monitoring Equipment | Out of Business | |
Peptimmune | 17-Jan-2008 | 00000 00000 | 000.00 | Pharmaceuticals | Bankruptcy: Liquidation | |
Sirtris Pharmaceuticals | 06-Feb-2007 | Later Stage VC | 0000 | Pharmaceuticals | Generating Revenue | |
Morphotek | 13-Oct-2006 | Later Stage VC | 0000 | Drug Discovery | Clinical Trials - Phase 2 |
Hunt BioVentures Exits (14)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
InteKrin | 12-Feb-2014 | Merger/Acquisition | 000 |
Revance Therapeutics | 06-Feb-2014 | 000 | 0000 |
MacroGenics | 10-Oct-2013 | 000 | 000.00 |
OvaScience | 12-Nov-2012 | 000 | 000.00 |
Cempra Pharmaceuticals | 03-Feb-2012 | 000 | 000.00 |
Synageva BioPharma | 03-Nov-2011 | 0000000 000000 | 00000 |
Peptimmune | 23-Mar-2011 | 0000000000: 000000 | |
Athenix | 02-Nov-2009 | 000000000000000000 | 00000 |
IntelliDx | 01-Jan-2009 | Bankruptcy: Liquidation | |
Sirtris Pharmaceuticals | 05-Jun-2008 | Merger/Acquisition | 00000 |